Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Andropause Accelerates Aβ Deposition in Mice
26 December 2006. Testosterone levels decline as men age, and the urge to treat this natural process with hormone replacement has sparked controversy lately, because the risks and benefits of such a course are not well known. One recently appreciated down side to testosterone loss is an increased risk of developing Alzheimer disease (Moffat et al., 2004; Rosario et al., 2004). A paper out this week in the Journal of Neuroscience, from Christian Pike’s lab at the University of Southern California in Los Angeles, shows that in a mouse model of AD, androgen depletion accelerates the age-dependent appearance of Aβ plaques and cognitive defects, while replacement therapy slows the process down. The results demonstrate one way that age-related testosterone loss could increase the risk of AD in men and support the idea that replacement therapy might be useful for the treatment or prevention of AD (see ARF related news story).

To understand the relationship between androgens and AD, first author Emily Rosario looked at the effect of androgen depletion on pathology in the triple transgenic AD mouse model (APPswe, PS1M146V, tauP301L) created in coauthor Frank LaFerla’s lab. When the researchers removed the animals’ testes at 3 months of age, the gonadectomized mice showed an increase in Aβ load in the brain at 7 months compared to their unaltered littermates. The accelerated Aβ accumulation was prevented by starting testosterone replacement at the time of surgery. Parallel to the Aβ accumulation, the researchers detected more severe deficits in a spontaneous alternation test in androgen-deprived mice. The behavior, which relies on hippocampal-dependent working memory, was also normalized by hormone replacement.

The pathway linking testosterone and Aβ accumulation is unknown, but the results are consistent with an increase in Aβ that was observed in normal rats after gonadectomy (Ramsden et al., 2003).

“Our findings extend a growing literature indicating that androgens can benefit cognitive abilities significantly by mechanisms that may include a reduction in Aβ levels,” the authors conclude. “The findings not only demonstrate a significant role of androgen depletion in AD pathogenesis, but also predict that androgen-based therapeutics may function effectively in the prevention of AD,” they write.—Pat McCaffrey.

Reference:
Rosario ER, Carroll JC, Oddo S, Laferla FM, Pike CJ. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci. 2006 Dec 20; 26(51):13384-9. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad